Philippe Levêque

439 total citations
15 papers, 365 citations indexed

About

Philippe Levêque is a scholar working on Radiology, Nuclear Medicine and Imaging, Biomaterials and Cancer Research. According to data from OpenAlex, Philippe Levêque has authored 15 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Biomaterials and 3 papers in Cancer Research. Recurrent topics in Philippe Levêque's work include Medical Imaging Techniques and Applications (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Philippe Levêque is often cited by papers focused on Medical Imaging Techniques and Applications (6 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Philippe Levêque collaborates with scholars based in Belgium, Chile and United States. Philippe Levêque's co-authors include Bernard Gallez, Daniel Labar, Anne Bol, Julien Verrax, Nicolas Dejeans, Pedro Buc Calderón, Christophe Glorieux, Raphaël Beck, Caroline Bouzin and Olivier Féron and has published in prestigious journals such as PLoS ONE, Oncotarget and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Philippe Levêque

15 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Levêque Belgium 11 148 124 89 67 64 15 365
Wendy Graham United States 12 273 1.8× 184 1.5× 73 0.8× 73 1.1× 47 0.7× 13 662
Yoichi Shimizu Japan 12 97 0.7× 154 1.2× 76 0.9× 64 1.0× 121 1.9× 28 484
Istvan Szanda United Kingdom 8 263 1.8× 90 0.7× 144 1.6× 52 0.8× 20 0.3× 10 516
John L. Mikitsh United States 8 79 0.5× 125 1.0× 99 1.1× 41 0.6× 17 0.3× 10 423
Nicholas Bernards Canada 13 75 0.5× 147 1.2× 163 1.8× 113 1.7× 36 0.6× 36 489
Valeria Catanzaro Italy 11 79 0.5× 167 1.3× 51 0.6× 20 0.3× 56 0.9× 15 426
Wonjung Kwak South Korea 10 130 0.9× 195 1.6× 64 0.7× 30 0.4× 27 0.4× 11 407
Jamila Hedhli United States 12 70 0.5× 217 1.8× 274 3.1× 47 0.7× 43 0.7× 18 538
Sylvain Dukic France 11 57 0.4× 122 1.0× 78 0.9× 39 0.6× 28 0.4× 20 420

Countries citing papers authored by Philippe Levêque

Since Specialization
Citations

This map shows the geographic impact of Philippe Levêque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Levêque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Levêque more than expected).

Fields of papers citing papers by Philippe Levêque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Levêque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Levêque. The network helps show where Philippe Levêque may publish in the future.

Co-authorship network of co-authors of Philippe Levêque

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Levêque. A scholar is included among the top collaborators of Philippe Levêque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Levêque. Philippe Levêque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Danhier, Pierre, Gladys Deumer, Nicolas Joudiou, et al.. (2017). Contribution of macrophages in the contrast loss in iron oxide-based MRI cancer cell tracking studies. Oncotarget. 8(24). 38876–38885. 6 indexed citations
2.
Karmani, Linda, Philippe Levêque, Caroline Bouzin, et al.. (2016). Biodistribution of 125I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice. Nuclear Medicine and Biology. 43(7). 415–423. 11 indexed citations
3.
Karmani, Linda, V. Bouchat, Caroline Bouzin, et al.. (2014). 89 Zr-Labeled Anti-Endoglin Antibody-Targeted Gold Nanoparticles for Imaging Cancer: Implications for Future Cancer Therapy. Nanomedicine. 9(13). 1923–1937. 30 indexed citations
4.
Mignion, Lionel, Oussama Karroum, Julie Magat, et al.. (2014). Influence of paramagnetic melanin on the MRI contrast in melanoma: a combined high‐field (11.7 T) MRI and EPR study. Contrast Media & Molecular Imaging. 9(2). 154–160. 13 indexed citations
5.
Karmani, Linda, Daniel Labar, V. Bouchat, et al.. (2013). Antibody‐functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr‐labeled cetuximab in mice. Contrast Media & Molecular Imaging. 8(5). 402–408. 76 indexed citations
6.
Karroum, Oussama, Lionel Mignion, Linda Karmani, et al.. (2013). Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion‐weighted MRI, choline spectroscopy and 18F‐FLT PET imaging. Contrast Media & Molecular Imaging. 8(3). 274–280. 8 indexed citations
7.
Beck, Raphaël, Nicolas Dejeans, Christophe Glorieux, et al.. (2012). Hsp90 Is Cleaved by Reactive Oxygen Species at a Highly Conserved N-Terminal Amino Acid Motif. PLoS ONE. 7(7). e40795–e40795. 58 indexed citations
8.
Beck, Raphaël, Rozangela Curi Pedrosa, Nicolas Dejeans, et al.. (2010). Ascorbate/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study. Investigational New Drugs. 29(5). 891–900. 56 indexed citations
9.
Mahy, Pierre, Xavier Geets, Max Lonneux, et al.. (2008). Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism. European Journal of Nuclear Medicine and Molecular Imaging. 35(7). 1282–1289. 32 indexed citations
10.
Mahy, Pierre, Marc De Bast, Philippe Levêque, et al.. (2004). Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3. European Journal of Nuclear Medicine and Molecular Imaging. 31(9). 1263–72. 28 indexed citations
11.
Levêque, Philippe, Sandra Sanabria Bohórquez, Anne Bol, et al.. (2003). Quantification of human brain benzodiazepine receptors using [18F]fluoroethylflumazenil: a first report in volunteers and epileptic patients. European Journal of Nuclear Medicine and Molecular Imaging. 30(12). 1630–1636. 10 indexed citations
12.
Levêque, Philippe, Daniel Labar, & Bernard Gallez. (2001). Biodistribution, binding specificity and metabolism of [ 18 F]fluoroethylflumazenil in rodents. Nuclear Medicine and Biology. 28(7). 809–814. 12 indexed citations
13.
Levêque, Philippe, Edmond de Hoffmann, Daniel Labar, & Bernard Gallez. (2001). Assessment of [18F]fluoroethylflumazenil metabolites using high-performance liquid chromatography and tandem mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 754(1). 35–44. 8 indexed citations
14.
Bohórquez, Sandra Sanabria, Daniel Labar, Philippe Levêque, et al.. (2000). [11C]Flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification. European Journal of Nuclear Medicine and Molecular Imaging. 27(11). 1674–1683. 16 indexed citations
15.
Poupaert, Jacques H., et al.. (1996). Reaction of aryl isothiocyanates with phthalic acid derivatives. Bulletin des Sociétés Chimiques Belges. 105(1). 55–56. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Graham Breakdown of academic impact, for papers by Yoichi Shimizu Breakdown of academic impact, for papers by Istvan Szanda Breakdown of academic impact, for papers by John L. Mikitsh Breakdown of academic impact, for papers by Nicholas Bernards Breakdown of academic impact, for papers by Valeria Catanzaro Breakdown of academic impact, for papers by Wonjung Kwak Breakdown of academic impact, for papers by Jamila Hedhli Breakdown of academic impact, for papers by Sylvain Dukic
Rankless by CCL
2026